Noticias de LLY

Noticias del mercado

Últimas noticias sobre LLY — 1109 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: LLY ✕ 1.109 resultados
19/04/2026 LLY_US — Seeking Alpha ES ← EN
Eli Lilly se acerca a un acuerdo de más de 2.000 millones de dólares para que Kelonia amplíe su cartera de cáncer: WSJ (LLY:NYSE)
19/04/2026 LLY_US — CNBC
Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says
17/04/2026 LLY_US — Yahoo Finance
Eli Lilly and Company (LLY) Price Target Increased At Morgan Stanley on Updated Biopharma Model Assumptions
16/04/2026 LLY_US — investor.lilly.com
ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
16/04/2026 LLY_US — PR Newswire
ACHIEVE-4, the longest Phase 3 study of Lilly's Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
16/04/2026 LLY_US — Fox 59
Braun signs nuclear energy-related letter of intent with Eli Lilly and Company
16/04/2026 LLY_US — investor.lilly.com
Lilly confirms date and conference call for first-quarter 2026 financial results announcement
16/04/2026 LLY_US — Quiver Quantitative
Lobbying Update: $120,000 of ELI LILLY AND COMPANY lobbying was just disclosed | LLY Stock News
14/04/2026 LLY_US — TMC Houston ES ← EN
Texas Medical Center Venture Fund anuncia la adquisición de CrossBridge Bio por $ 300 millones por parte de Eli Lilly
14/04/2026 LLY_US — BioSpace ES ← EN
Lilly quiere cerrar la brecha en la atención del cáncer con la compra de biotecnología de ADC por 300 millones de dólares
13/04/2026 LLY_US — Seeking Alpha
Even After Shedding Some Weight, Eli Lilly and Company Isn't Prime For Upgrade (NYSE:LLY)
10/04/2026 LLY_US — Yahoo Finance
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
10/04/2026 LLY_US — 24/7 Wall St.
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
10/04/2026 LLY_US — Yahoo Finance
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
09/04/2026 LLY_US — investor.lilly.com
Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S. | Eli Lilly and Company
09/04/2026 LLY_US — Yahoo Finance
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
09/04/2026 LLY_US — Business Wire
Amazon Pharmacy to Offer Eli Lilly and Company’s New GLP-1 Pill Foundayo via Same-Day Delivery
09/04/2026 LLY_US — PR Newswire ES ← EN
Foundayo™ (oforglipron), la nueva pastilla oral de GLP-1 de Lilly para bajar de peso, ya disponible en EE. UU.
09/04/2026 LLY_US — Pharmaceutical Commerce ES ← EN
GoodRx y Eli Lilly se asocian para ampliar el acceso a Foundayo y Zepbound KwikPen
09/04/2026 LLY_US — Business Wire
GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

Página 54 de 56

keyboard_arrow_up